Try our beta test site

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Hoosier Cancer Research Network
Sponsor:
Collaborators:
Hoosier Cancer Research Network
Vera Bradley Foundation for Breast Cancer
Walther Cancer Institute
Strategic Research Initiative Grant through IUSCC
Information provided by (Responsible Party):
Bryan Schneider, MD, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT02101385
First received: March 21, 2014
Last updated: January 19, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)